Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3EQR

Crystal Structure of Ack1 with compound T74

Summary for 3EQR
Entry DOI10.2210/pdb3eqr/pdb
Related3EQP
DescriptorActivated CDC42 kinase 1, N~3~-(2,6-dimethylphenyl)-1-(3-methoxy-3-methylbutyl)-N~6~-(4-piperazin-1-ylphenyl)-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine, CHLORIDE ION, ... (4 entities in total)
Functional Keywordsack1, alternative splicing, atp-binding, cell membrane, kinase, magnesium, membrane, metal-binding, nucleotide-binding, phosphoprotein, polymorphism, sh3 domain, transferase, tyrosine-protein kinase
Biological sourceHomo sapiens (human)
Cellular locationCell membrane: Q07912
Total number of polymer chains2
Total formula weight64141.57
Authors
Liu, J.,Wang, Z.,Walker, N.P.C. (deposition date: 2008-10-01, release date: 2008-12-02, Last modification date: 2023-12-27)
Primary citationKopecky, D.J.,Hao, X.,Chen, Y.,Fu, J.,Jiao, X.,Jaen, J.C.,Cardozo, M.G.,Liu, J.,Wang, Z.,Walker, N.P.,Wesche, H.,Li, S.,Farrelly, E.,Xiao, S.H.,Kayser, F.
Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.
Bioorg.Med.Chem.Lett., 18:6352-6356, 2008
Cited by
PubMed Abstract: A new series of pyrazolo[3,4-d]pyrimidine-3,6-diamines was designed and synthesized as potent and selective inhibitors of the nonreceptor tyrosine kinase, ACK1. These compounds arose from efforts to rigidify an earlier series of N-aryl pyrimidine-5-carboxamides. The synthesis and structure-activity relationships of this new series of inhibitors are reported. The most promising compounds were also profiled for their pharmacokinetic properties.
PubMed: 18993068
DOI: 10.1016/j.bmcl.2008.10.092
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon